Financhill
Back

Krystal Biotech Vs. Axsome Therapeutics Industry Stock Comparison

Sell
34

KRYS
Krystal Biotech

Last Price:
171.06
Seasonality Move:
17.47%
Buy
63

AXSM
Axsome Therapeutics

Last Price:
87.16
Seasonality Move:
50.2%
Sell
34
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $176.39. The Score for KRYS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Axsome Therapeutics (AXSM) is a Buy

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $88.84. The Score for AXSM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • AXSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $176.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $88.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2 Sell
Relative Strength Index (14 RSI): 47.3 Sell
Chaikin Money Flow: 286417 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (174.03 - 179.13) Sell
Bollinger Bands (100): (175.89 - 198.49) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 47.74 Sell
Chaikin Money Flow: -199767 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.97 - 91.79) Sell
Bollinger Bands (100): (80.74 - 91.6) Buy

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 175.09 Buy
20-day SMA: 176.03 Buy
50-day SMA: 183.43 Sell
200-day SMA: 170.35 Buy
8-day EMA: 175.5 Buy
20-day EMA: 176.89 Sell
50-day EMA: 180.88 Sell
200-day EMA: 168.84 Buy

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.84 Sell
20-day SMA: 88.37 Buy
50-day SMA: 90.07 Sell
200-day SMA: 82.42 Buy
8-day EMA: 89.54 Sell
20-day EMA: 89.48 Sell
50-day EMA: 88.81 Buy
200-day EMA: 82.65 Buy

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.18 per share, and an increase next year of $2.01 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.95 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.39 per share, and an increase next year of $3.89 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):